Intellia Therapeutics Overview
Intellia Therapeutics Target Price
Analysts' 12-month price predictions for NTLA.
Share Price
$12.06
Average Target Price
$14.00
16.1% upside
16.1% upside1 analysts in the last 4 months
High: $14 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-13 | GuggenheimDebjit Chattopadhyay | $14 | 16.1% upside |  |
| 2025-02-28 | Goldman Sachs | $9 |  25.4% downside | |
| 2025-02-28 | Barclays | $26 | 115.6% upside | |
| 2024-11-11 | OppenheimerJay Olson | $60 | 397.5% upside | |
| 2024-10-24 | Robert W. BairdJack Allen | $18 | 49.3% upside | |
| 2024-08-09 | RBC CapitalLuca Issi | $54 | 347.8% upside | |
| 2024-06-24 | Stifel NicolausDae Gon Ha | $80 | 563.3% upside | |
| 2024-06-24 | Robert W. BairdJack Allen | $24 | 99% upside | |
| 2024-05-10 | BMO CapitalKostas Biliouris | $70 | 480.4% upside | |
| 2023-02-01 | Cantor Fitzgerald | $67 | 455.6% upside | |
| 2023-01-04 | Wells Fargo | $120 | 895% upside | |
| 2022-12-06 | Credit Suisse | $88 | 629.7% upside | |
| 2022-12-02 | Leerink Partners | $86 | 613.1% upside | |
| 2022-11-15 | Chardan Capital | $129 | 969.7% upside | |
| 2022-08-05 | Leerink Partners | $152 | 1160.4% upside | |
| 2022-08-05 | Chardan Capital | $146 | 1110.6% upside | |
| 2022-06-16 | BMO CapitalKostas Biliouris | $54 | 347.8% upside | |
| 2022-05-09 | JMP Securities | $110 | 812.1% upside | |
| 2022-05-09 | Raymond JamesSteven Seedhouse | $105 | 770.6% upside | |
| 2022-05-06 | Credit Suisse | $98 | 712.6% upside | |
| 2022-02-24 | RBC CapitalLuca Issi | $150 | 1143.8% upside | |
| 2022-02-18 | William BlairRaju Prasad | $144 | 1094% upside | |
| 2022-02-15 | Truist FinancialJoon Lee | $160 | 1226.7% upside | |
| 2022-02-03 | Piper SandlerSwapnil Malekar | $171 | 1317.9% upside | |
| 2022-02-03 | WedbushDavid Nierengarten | $108 | 795.5% upside | |
| 2021-11-16 | Roth CapitalAnthony Butler | $180 | 1392.5% upside | |
| 2021-08-06 | Raymond JamesSteven Seedhouse | $181 | 1400.8% upside | |
| 2021-08-06 | Goldman SachsSalveen Richter | $252 | 1989.6% upside | |
| 2021-08-05 | BarclaysGena Wang | $207 | 1616.4% upside | |
| 2021-06-22 | JefferiesMaury Raycroft | $109 | 803.8% upside | |